These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33996350)

  • 1. Perspectives on urological care in multiple sclerosis patients.
    Moussa M; Abou Chakra M; Papatsoris AG; Dabboucy B; Hsieh M; Dellis A; Fares Y
    Intractable Rare Dis Res; 2021 May; 10(2):62-74. PubMed ID: 33996350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower urinary tract dysfunction in patients with multiple sclerosis.
    Panicker JN; Fowler CJ
    Handb Clin Neurol; 2015; 130():371-81. PubMed ID: 26003255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturia in Patients With Multiple Sclerosis.
    Peyronnet B; Krupp LB; Reynolds WS; Gamé X; Amarenco G; Cornu JN; Ryerson LZ; Sammarco CL; Howard JE; Charlson RW; Dmochowski RR; Brucker BM
    Rev Urol; 2019; 21(2-3):63-73. PubMed ID: 31768133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
    Leippold T; Reitz A; Schurch B
    Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic lower urinary tract dysfunction.
    Panicker JN; De Sèze M; Fowler CJ
    Handb Clin Neurol; 2013; 110():209-20. PubMed ID: 23312642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenic lower urinary tract dysfunction: evaluation and management.
    Tudor KI; Sakakibara R; Panicker JN
    J Neurol; 2016 Dec; 263(12):2555-2564. PubMed ID: 27401178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
    Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
    Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urological manifestations of chronic schistosomal myeloradiculopathy.
    Gomes CM; Hisano M; Machado LR; Figueiredo JA; Lucon AM; Trigo-Rocha FE
    BJU Int; 2005 Oct; 96(6):853-6. PubMed ID: 16153216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and rehabilitation of neurologic patients with lower urinary tract dysfunction.
    Drake MJ
    Handb Clin Neurol; 2015; 130():451-68. PubMed ID: 26003260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of neurogenic bladder in patients with multiple sclerosis.
    Phé V; Chartier-Kastler E; Panicker JN
    Nat Rev Urol; 2016 May; 13(5):275-88. PubMed ID: 27030526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voiding dysfunction due to multiple sclerosis: a large scale retrospective analysis.
    Onal B; Siva A; Buldu I; Demirkesen O; Cetinel B
    Int Braz J Urol; 2009; 35(3):326-33. PubMed ID: 19538768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower urinary tract dysfunction in common neurological diseases.
    Moussa M; Papatsoris A; Chakra MA; Fares Y; Dellis A
    Turk J Urol; 2020 Nov; 46(Supp. 1):S70-S78. PubMed ID: 32384046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early urological care of patients with spinal cord injury.
    Welk B; Schneider MP; Thavaseelan J; Traini LR; Curt A; Kessler TM
    World J Urol; 2018 Oct; 36(10):1537-1544. PubMed ID: 29948046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomal myelopathy: urologic manifestations and urodynamic findings.
    Gomes CM; Trigo-Rocha F; Arap MA; Gabriel AJ; Alaor de Figueiredo J; Arap S
    Urology; 2002 Feb; 59(2):195-200. PubMed ID: 11834384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of urethral and bladder dysfunction.
    Chuang YC; Smith CP; Somogyi GT; Chancellor MB
    J Formos Med Assoc; 2003 Jan; 102(1):5-11. PubMed ID: 12684605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on the urological care in Parkinson's disease patients.
    Moussa M; Abou Chakra M; Papatsoris AG; Dellis A; Dabboucy B; Peyromaure M; Barry Delongchamps N; Bailly H; Duquesne I
    Arch Ital Urol Androl; 2022 Mar; 94(1):107-117. PubMed ID: 35352535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.
    Panicker JN; de Sèze M; Fowler CJ
    Clin Rehabil; 2010 Jul; 24(7):579-89. PubMed ID: 20584864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.